Topiramate versus migraine: Which is the cause of glaucomatous visual field defects? [3]

Headache

Volumn 42, Issue 8, 2002, Pages 837-838

  Di Legge, Silvia ^a   Bruti, Gianluca ^a   Di Piero, Vittorio ^a   Lenzi, Gianluigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

GLAUCOMA; HUMAN; LETTER; MIGRAINE; PERIMETRY; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

ANTICONVULSANTS; FRUCTOSE; GLAUCOMA; HUMANS; MIGRAINE DISORDERS; VISION DISORDERS; VISUAL FIELDS;

EID: 0036753991     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02196.x     Document Type: Letter

References (12)

1. Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Invest Drugs. 2001;10(10):1831-1845.
2. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: A double-blind, placebo-controlled study. Headache. 2001;41(10):968-975.
3. Midelfart A, Midelfart E, Brodtkorb E. Visual field defects in patients taking vigabatrin. Acta Ophthalmol Scand. 2000;78(5):580-584.
4. Sen HA, O'Halloran HS, Lee WB. Case reports and small case series: Topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119(5):775-777.
5. Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Opthalmol. 2001;132(1):112-114.
6. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001; 119(8):1210-1211.
7. Cursiefen C, Wisse M, Cursiefen S, Junemann A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol. 2000;129(1):102-104.
8. Cerovski B, Car Z, Brzovic Z, Sikic J. Classic migraine and visual field defects. Acta Med Croatica. 1995;49(3):127-131.
9. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci. 2000;41(5):1239-1247.
10. Di Legge S, De Gregorio F, Di Piero V, Di Stani F, Bruti G, Sedran L, et al. Subclinical glaucomatous alterations in migraine: A study by the frequency-doubling technology perimetry. Cephalalgia. 2001;21(4):391.
11. McColl SL, Wilkinson F. Migraineurs show visual field defects on motion coherence perimetry during the interictal period. Cephalalgia. 2001;21(4):391.
12. Maddess T, Goldberg I, Dobinson J, Wine S, Welsh AH, James AC. Testing for glaucoma with the spatial frequency doubling illusion. Vision Res. 1999; 39(25):4158-4273.